靶点- |
作用机制- |
|
原研机构- |
|
非在研适应症- |
最高研发阶段临床1期 |
首次获批国家/地区- |
首次获批日期- |
A Randomized, Double-masked, Multicenter, Placebo Controlled Study of Keluo Xin Capsule on Efficacy and Safety in Patients With Diabetic Retinopathy
This is a study aiming to assess the efficacy and safety of Keluo Xin capsule in patients with moderately severe to severe nonproliferative diabetic retinopathy (NPDR). Two-thirds of participates will receive Keluo Xin capsules while other one third will receive placebo.
100 项与 成都康弘制药有限公司 相关的临床结果
0 项与 成都康弘制药有限公司 相关的专利(医药)
100 项与 成都康弘制药有限公司 相关的药物交易
100 项与 成都康弘制药有限公司 相关的转化医学